Alnylam Pharmaceuticals (NASDAQ:ALNY) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) in a research note released on Thursday morning. The firm issued a buy rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the stock. Sanford C. Bernstein began coverage on shares of Alnylam Pharmaceuticals in a research note […]

Related Keywords

Phillip Zamore ,Sanfordc Bernstein ,Thomas Tuschl ,David Bartel ,Pushkal Garg ,Alnylam Pharmaceuticals Company Profile ,Alnylam Pharmaceuticals Price Performance ,Orion Portfolio Solutions ,News Ratings For Alnylam Pharmaceuticals Daily ,Hedge Funds Weigh In On Alnylam Pharmaceuticals ,Analyst Recommendations For Alnylam Pharmaceuticals ,Pearl River Capital ,Morgan Stanley ,Insider Transactions At Alnylam Pharmaceuticals ,Jpmorgan Chase Co ,Alnylam Pharmaceuticals Inc ,First Republic Investment Management Inc ,Alnylam Pharmaceuticals ,Securities Exchange Commission ,Get Rating ,Moderate Buy ,Exchange Commission ,Lall Franchini ,River Capital ,Republic Investment Management ,Noble Laureate ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Initiated Coverage ,Stocknews Com ,